NO171994C - Fremgangsmaate for fremstilling av dihydroxylerte 11beta-(4-acetylfenyl)-17beta-hydroxy-17alfa-(1-propynyl)-4,9-estradien-3-oner - Google Patents

Fremgangsmaate for fremstilling av dihydroxylerte 11beta-(4-acetylfenyl)-17beta-hydroxy-17alfa-(1-propynyl)-4,9-estradien-3-oner

Info

Publication number
NO171994C
NO171994C NO860425A NO860425A NO171994C NO 171994 C NO171994 C NO 171994C NO 860425 A NO860425 A NO 860425A NO 860425 A NO860425 A NO 860425A NO 171994 C NO171994 C NO 171994C
Authority
NO
Norway
Prior art keywords
17alfa
estradien
11beta
oner
17beta
Prior art date
Application number
NO860425A
Other languages
English (en)
Norwegian (no)
Other versions
NO860425L (no
NO171994B (no
Inventor
Guenter Neef
Sybille Beier
Walter Elger
David Henderson
Eckard Ottow
Ralph Rohde
Rudolf Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853504421 external-priority patent/DE3504421A1/de
Priority claimed from DE19853527517 external-priority patent/DE3527517A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO860425L publication Critical patent/NO860425L/no
Priority to NO864209A priority Critical patent/NO170285C/no
Publication of NO171994B publication Critical patent/NO171994B/no
Publication of NO171994C publication Critical patent/NO171994C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO860425A 1985-02-07 1986-02-06 Fremgangsmaate for fremstilling av dihydroxylerte 11beta-(4-acetylfenyl)-17beta-hydroxy-17alfa-(1-propynyl)-4,9-estradien-3-oner NO171994C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO864209A NO170285C (no) 1985-02-07 1986-10-21 13-alkyl-llbeta-fenyl-gonaner, og antikonsepsjonsmiddel inneholdende disse

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853504421 DE3504421A1 (de) 1985-02-07 1985-02-07 Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate
DE19853527517 DE3527517A1 (de) 1985-07-29 1985-07-29 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate

Publications (3)

Publication Number Publication Date
NO860425L NO860425L (no) 1986-08-08
NO171994B NO171994B (no) 1993-02-15
NO171994C true NO171994C (no) 1993-05-26

Family

ID=25829248

Family Applications (1)

Application Number Title Priority Date Filing Date
NO860425A NO171994C (no) 1985-02-07 1986-02-06 Fremgangsmaate for fremstilling av dihydroxylerte 11beta-(4-acetylfenyl)-17beta-hydroxy-17alfa-(1-propynyl)-4,9-estradien-3-oner

Country Status (16)

Country Link
US (1) US5089635A (da)
EP (1) EP0190759B1 (da)
CN (1) CN1033753C (da)
AU (1) AU580843B2 (da)
CA (1) CA1310630C (da)
DE (1) DE3665307D1 (da)
DK (1) DK161709C (da)
ES (1) ES8701778A1 (da)
FI (1) FI85377C (da)
GR (1) GR860342B (da)
HU (1) HU194904B (da)
IE (1) IE58149B1 (da)
IL (1) IL77762A (da)
NO (1) NO171994C (da)
NZ (1) NZ214998A (da)
PT (1) PT81969B (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
GB8513723D0 (en) * 1985-05-31 1985-07-03 Erba Farmitalia 11-beta substituted steroids
DE3866410D1 (de) * 1987-04-24 1992-01-09 Akzo Nv 11-arylestranderivate und 11-arylpregnanderivate.
AU625450B2 (en) * 1987-07-16 1992-07-09 Schering Aktiengesellschaft Berlin Und Bergkamen 11beta-phenyl-4,9,15-estratrienes, their manufacture, and pharmaceutical preparations containing them
DE3723788A1 (de) * 1987-07-16 1989-01-26 Schering Ag 11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
ES2053714T3 (es) * 1987-12-12 1994-08-01 Akzo Nv Proceso para la preparacion de 11-arilesteroides.
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
FR2665901B2 (fr) * 1989-02-24 1994-07-29 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
ES2189784T3 (es) * 1989-07-07 2003-07-16 Endorech Inc Procedimiento para el tratamiento de enfermedades relacionadas con adrogenos.
DE69032648T2 (de) * 1989-07-07 1999-04-08 Endorecherche Inc., Ste-Foy, Quebec Androgenderivate zur Hemming der Aktivität der Sexualsteroide
ATE172469T1 (de) * 1989-08-04 1998-11-15 Schering Ag 11 beta-aryl-gona-4,9-dien-3-one
DE4042007A1 (de) * 1990-12-22 1992-06-25 Schering Ag 6,7-modifizierte-11(beta)-aryl-4-estrene
DK0471612T3 (da) * 1990-08-14 1999-02-22 Hoechst Marion Roussel Inc Nye 19-nor steroider med carbonkæde omfattende en amidgruppe i 11-beta-stillingen, fremgangsmåde til deres fremstilling, de
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
FR2688004A1 (fr) * 1992-02-27 1993-09-03 Roussel Uclaf Nouveaux sterouides comportant en position 17 un radical methylene lactone, leur procede et des intermediaires de preparation, leur application comme medicaments.
WO1993023053A1 (en) * 1992-05-21 1993-11-25 Endorecherche Inc. INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5780220A (en) * 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
US5639598A (en) * 1994-05-19 1997-06-17 The Trustees Of The University Of Pennsylvania Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
CA2253673C (en) 1996-05-01 2009-09-08 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
IL122740A (en) * 1997-01-15 2003-09-17 Akzo Nobel Nv 16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them
US6090798A (en) * 1997-12-19 2000-07-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with glucocorticoid antagonists
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
EP1285927A3 (de) * 2001-08-16 2005-06-29 Schering Aktiengesellschaft Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems
DE10236405A1 (de) * 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
DE102009034367A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
US11103514B2 (en) 2010-05-26 2021-08-31 Corcept Therapeutics, Inc. Treatment of muscular dystrophy
JP6821582B2 (ja) 2015-03-02 2021-01-27 コーセプト セラピューティクス， インコーポレイテッド Ａｃｔｈ分泌腫瘍を処置するための糖質コルチコイドレセプターアンタゴニストおよびソマトスタチンアナログの使用
EP3277281B1 (en) 2015-03-30 2022-01-05 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
WO2017027851A1 (en) 2015-08-13 2017-02-16 Corcept Therapeutics, Inc. Method for differentially diagnosing acth-dependent cushing's syndrome
WO2017127448A1 (en) 2016-01-19 2017-07-27 Corcept Therapeutics, Inc. Differential diagnosis of ectopic cushing's syndrome
AU2018244928B2 (en) 2017-03-31 2023-10-19 Corcept Therapeutics, Inc. Glucocorticoid receptor modulators to treat cervical cancer
US11213526B2 (en) 2017-06-20 2022-01-04 Corcept Therapeutics, Inc. Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
EP4263807A2 (en) 2020-12-18 2023-10-25 Instil Bio (Uk) Limited Processing of tumor infiltrating lymphocytes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
DE3231827A1 (de) * 1982-08-24 1984-03-01 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-17(alpha)-alkinyl-17ss-hydroxy-4,9(10)- estradien-3-on-derivate, deren herstellung und diese enthaltende pharmazeutische praeparate
FR2573657B1 (fr) * 1984-11-29 1989-05-12 Roussel Uclaf Produit comprenant une substance antiprogestomimetique et une substance uterotonique
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
HU194904B (en) 1988-03-28
FI860559A (fi) 1986-08-08
GR860342B (en) 1986-06-03
FI85377C (fi) 1992-04-10
ES8701778A1 (es) 1986-12-16
DE3665307D1 (en) 1989-10-05
NZ214998A (en) 1989-06-28
US5089635A (en) 1992-02-18
PT81969B (pt) 1988-03-03
CN86100994A (zh) 1986-10-08
EP0190759A2 (de) 1986-08-13
EP0190759B1 (de) 1989-08-30
FI85377B (fi) 1991-12-31
IE860334L (en) 1986-08-07
CN1033753C (zh) 1997-01-08
AU5291386A (en) 1986-08-14
EP0190759A3 (en) 1986-11-20
NO860425L (no) 1986-08-08
HUT40453A (en) 1986-12-28
DK161709C (da) 1992-01-13
DK161709B (da) 1991-08-05
PT81969A (de) 1986-03-01
DK56086A (da) 1986-08-08
DK56086D0 (da) 1986-02-05
IL77762A (en) 1992-08-18
NO171994B (no) 1993-02-15
ES551625A0 (es) 1986-12-16
FI860559A0 (fi) 1986-02-07
CA1310630C (en) 1992-11-24
IE58149B1 (en) 1993-07-14
AU580843B2 (en) 1989-02-02

Similar Documents

Publication Publication Date Title
NO171994C (no) Fremgangsmaate for fremstilling av dihydroxylerte 11beta-(4-acetylfenyl)-17beta-hydroxy-17alfa-(1-propynyl)-4,9-estradien-3-oner
DK162371C (da) Loefteindretning til handikappede
NO903920L (no) Fremgangsmaate for fremstilling av en isomerblanding.
NO865013D0 (no) Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater.
NO864108L (no) Fremgangsmaate for fremstilling av nye flavon-derivater.
NO861486L (no) Fremgangsmaate til fremstilling av fluorerte benzyltriazolforbindelser.
NO863251L (no) Fremgangsmaate for fremstilling av sphingosinderivater.
NO864515L (no) Fremgangsmaate for fremstilling av heterocyliske oxazoloner
NO862942D0 (no) Fremgangsmaate for fremstilling av kalsiumfluorsilikat.
NO860429L (no) Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
NO863389L (no) Fremgangsmaate til fremstilling av substituerte toluidiner.
NO863616L (no) Fremgangsmaate for fremstilling av n-sulfamyl-3-(2-guanidinothiazolo-4-yl-methylthio)-propionamid.
NO863343L (no) Fremgangsmaate for fremstilling av gem-dihalo-1,8-diamino-4-aza-octaner.
NO864446D0 (no) Fremgangsmaate til fremstilling av en oksydisk katalysatorforloeper.
NO164543C (no) Fremgangsmaate til fremstilling av n7-amidino substituerte mitomycin c-derivater.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
FI863883A0 (fi) Anordning foer tillslutning av flaskhals.
NO864087L (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO862493L (no) Fremgangsmaate for fremstilling av 2-halonicergolinderivater.
NO863045D0 (no) Fremgangsmaate for fremstilling av alkyl-2-karboalkoksy-3,4-dialkoksybenzenkarbamater.
FI864790A (fi) Foerfarande foer framstaellning av 5-klor- och 5-brom-2-hydroxinikotinsyror.
FI864736A0 (fi) Foerfarande foer framstaellning av 2-substituerade 5-nitroso-4,6-diamino-pyrimidiner.
NO900651D0 (no) Fremgangsmaate for fremstilling av 2-benzyl-1-nafthol.
NO864660D0 (no) Framgangsmaate for framstilling av bleket tremasse.
NO873567L (no) Fremgangsmaate for fremstilling av steroidforbindelser.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees